Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms

Journal of Cardiovascular Pharmacology
Qihang ZhangP M Scholz

Abstract

We tested the hypothesis that myocardial stunning would be reduced by increased cyclic GMP and cGMP protein kinase activity. Hearts were instrumented in eight open-chest anesthetized dogs. The left anterior descending coronary artery (LAD) was occluded for 15 minutes followed by a 30-minute recovery and infusion of 8-Bromo-cGMP (0.1 and 1 microg/kg/min) during functional and metabolic data collection. Myocytes from circumflex and LAD regions were then used to obtain data at baseline, with 8-Br-cGMP (10(-7, -6, -5) M) and KT5823 10(-6) M, cGMP protein kinase inhibitor. The in vivo time delay of regional shortening increased significantly from 55 +/- 12 to 99 +/- 3 msec following stunning, but was reduced to 81 +/- 2 by 1 microg/kg/min 8-Br-cGMP. The % regional work during systole decreased during stunning (93 +/- 2 to 76 +/- 8%), but was restored by 8-Br-cGMP (91 +/- 7). Stunning lengthened the time of myocyte contraction and relaxation and reduced baseline shortening. 8-Br-cGMP reduced myocyte shortening in both regions. However, KT5823 only restored myocyte shortening in controls. These data indicated that regional myocardial stunning could be reduced by cyclic GMP but this appeared to be through non-cGMP protein kinase mechan...Continue Reading

References

Nov 1, 1991·Basic Research in Cardiology·S M LohmannU Walter
Mar 1, 1990·Basic Research in Cardiology·E N DeanJ M Nicklas
Nov 1, 1988·Basic Research in Cardiology·G HeuschK Kröger
Dec 1, 1982·Circulation·E Braunwald, R A Kloner
May 1, 1997·Journal of Molecular and Cellular Cardiology·S SatoD E Vatner
Nov 20, 1998·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·L YanH R Weiss
Jul 14, 1999·Circulation·P G Danias, W J Manning
Nov 27, 1999·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·J Striessnig
Jan 19, 2000·Nitric Oxide : Biology and Chemistry·A GandhiH R Weiss
Feb 29, 2000·The Journal of Biological Chemistry·L H JiangD Wray
Mar 17, 2000·Proceedings of the Society for Experimental Biology and Medicine·R J LeoneH R Weiss
Jun 23, 2000·The Journal of Surgical Research·K N PatelP M Scholz
Oct 27, 2001·Circulation Research·S J KimS F Vatner
Mar 13, 2002·Critical Care Medicine·Mark G AngelosRobert T Gorsline
Jun 22, 2002·Annals of the New York Academy of Sciences·Buddhadeb Dawn, Roberto Bolli

❮ Previous
Next ❯

Citations

Apr 21, 2010·Cardiovascular Drugs and Therapy·Tao Tan, Harvey R Weiss
Mar 21, 2009·Clinical and Experimental Pharmacology & Physiology·Tao TanHarvey R Weiss
May 6, 2008·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jason A LucianoHarvey R Weiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Proceedings of the Society for Experimental Biology and Medicine
R J LeoneH R Weiss
Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
K L NaimJ Kedem
© 2022 Meta ULC. All rights reserved